Biomarkers and Future Targets for Development in Amyotrophic Lateral Sclerosis

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|21|31|3535-3550

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.21, Iss.31, 2014-10, pp. : 3535-3550

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Editorial (Thematic Issue: Emerging Biomarkers for Drug Development in Amyotrophic Lateral Sclerosis)

By  

Current Medicinal Chemistry, Vol. 21, Iss. 31, 2014-10 ,pp. : 3507-3507

Bentham Science Publishers

Access to resources Recommend Favorite

Glutamate excitotoxicity and therapeutic targets for amyotrophic lateral sclerosis

By Corona Juan C   Tovar-y-Romo Luis B   Tapia Ricardo  

Expert Opinion on Therapeutic Targets, Vol. 11, Iss. 11, 2007-11 ,pp. : 1415-1428

Informa Healthcare

Access to resources Recommend Favorite

New therapeutic targets for amyotrophic lateral sclerosis

By Kuzma-Kozakiewicz Magdalena   Kwiecinski Hubert  

Expert Opinion on Therapeutic Targets, Vol. 15, Iss. 2, 2011-02 ,pp. : 127-143

Informa Healthcare

Access to resources Recommend Favorite

Molecular Insights and Therapeutic Targets in Amyotrophic Lateral Sclerosis

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 7, Iss. 1, 2008-02 ,pp. : 11-19

Bentham Science Publishers

Access to resources Recommend Favorite

Diagnosis, Pathogenesis and Therapeutic Targets in Amyotrophic Lateral Sclerosis

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 9, Iss. 6, 2010-12 ,pp. : 764-778

Bentham Science Publishers

Access to resources Recommend Favorite